Search Results

Generic drug entry prior to patent expiration an FTC study

Download or Read eBook Generic drug entry prior to patent expiration an FTC study PDF written by and published by DIANE Publishing. This book was released on 2002 with total page 129 pages. Available in PDF, EPUB and Kindle.
Generic drug entry prior to patent expiration an FTC study
Author :
Publisher : DIANE Publishing
Total Pages : 129
Release :
ISBN-10 : 9781428951938
ISBN-13 : 1428951938
Rating : 4/5 (38 Downloads)

Book Synopsis Generic drug entry prior to patent expiration an FTC study by :

Book excerpt:


Generic drug entry prior to patent expiration an FTC study Related Books

Generic drug entry prior to patent expiration an FTC study
Language: en
Pages: 129
Authors:
Categories:
Type: BOOK - Published: 2002 - Publisher: DIANE Publishing

DOWNLOAD EBOOK

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
Language: en
Pages: 94
Authors:
Categories: Business & Economics
Type: BOOK - Published: 1998 - Publisher: U.S. Government Printing Office

DOWNLOAD EBOOK

Drug Wars
Language: en
Pages: 165
Authors: Robin Feldman
Categories: Law
Type: BOOK - Published: 2017-06-09 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competi
ANDA Litigation
Language: en
Pages: 0
Authors: Kenneth L. Dorsney
Categories: Biotechnology
Type: BOOK - Published: 2012 - Publisher: American Bar Association

DOWNLOAD EBOOK

Examining the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and U.S. patent law in the context of Parag
Generic Drug Entry Prior to Patent Expiration
Language: en
Pages:
Authors: United States. Federal Trade Commission
Categories: Drugs
Type: BOOK - Published: 2002 - Publisher:

DOWNLOAD EBOOK

In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendme
Scroll to top